Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Probuphine
    • Ropinirole Implant
    • T3 Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Titan FCOI Policy
    • Financial Info
    • Financials
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Reports First Quarter 2020 Financial Results

May 15, 2020

Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020

May 11, 2020

Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2019 Financial Results

March 30, 2020

Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020

March 26, 2020

Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants

March 5, 2020

Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule

January 13, 2020

Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering

January 7, 2020

Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors

December 30, 2019

Titan Pharmaceuticals To Present At The First Annual BioTuesdays Pre-JPM Virtual Conference

December 3, 2019

Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results

November 14, 2019

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...23
  • Next »
© 2021 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap